Immunovia AB (publ) (STO:IMMNOV)

Immunovia AB Statistics

Total Valuation

Immunovia AB has a market cap or net worth of SEK 116.51 million. The enterprise value is 39.90 million.

Market Cap	116.51M
Enterprise Value	39.90M

Important Dates

The last earnings date was Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Immunovia AB has 672.67 million shares outstanding. The number of shares has increased by 316.79% in one year.

Current Share Class	672.67M
Shares Outstanding	672.67M
Shares Change (YoY)	+316.79%
Shares Change (QoQ)	+77.69%
Owned by Insiders (%)	5.72%
Owned by Institutions (%)	11.75%
Float	633.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	170.08
PB Ratio	1.80
P/TBV Ratio	2.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.27
EV / Sales	58.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.01.

Current Ratio	3.42
Quick Ratio	3.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.22

Financial Efficiency

Return on equity (ROE) is -382.06% and return on invested capital (ROIC) is -129.06%.

Return on Equity (ROE)	-382.06%
Return on Assets (ROA)	-82.94%
Return on Invested Capital (ROIC)	-129.06%
Return on Capital Employed (ROCE)	-124.28%
Weighted Average Cost of Capital (WACC)	63.74%
Revenue Per Employee	52,692
Profits Per Employee	-11.22M
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.50% in the last 52 weeks. The beta is 2.76, so Immunovia AB's price volatility has been higher than the market average.

Beta (5Y)	2.76
52-Week Price Change	-55.50%
50-Day Moving Average	0.20
200-Day Moving Average	0.39
Relative Strength Index (RSI)	46.38
Average Volume (20 Days)	7,671,415

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Immunovia AB had revenue of SEK 685,000 and -145.92 million in losses. Loss per share was -0.42.

Revenue	685,000
Gross Profit	549,000
Operating Income	-80.45M
Pretax Income	-145.92M
Net Income	-145.92M
EBITDA	-78.13M
EBIT	-80.45M
Loss Per Share	-0.42

Balance Sheet

The company has 77.46 million in cash and 857,000 in debt, with a net cash position of 76.60 million or 0.11 per share.

Cash & Cash Equivalents	77.46M
Total Debt	857,000
Net Cash	76.60M
Net Cash Per Share	0.11
Equity (Book Value)	64.74M
Book Value Per Share	0.10
Working Capital	56.93M

Cash Flow

Operating Cash Flow	-78.40M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	80.15%
Operating Margin	-11,744.82%
Pretax Margin	-21,301.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunovia AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-316.79%
Shareholder Yield	-316.79%
Earnings Yield	-125.24%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Immunovia AB has an Altman Z-Score of -19.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.05
Piotroski F-Score	2